Quintiles Enters Malaysia Clinical Trial Alliance For First Prime Site In Asia
This article was originally published in PharmAsia News
SINGAPORE - Quintiles has entered an alliance with the University Malaya Medical Centre, creating its first clinical trial Prime Site in Asia, which is focused on accelerating drug development
You may also be interested in...
The Ministry of Health lessens its reliance on counterpart agencies as it rolls out new pharmacoeconomic guidelines.
Malaysia readies to launch venture capital fund worth $100 million in the second quarter to support biopharma industry.
SEOUL - Seoul National University Hospital, which is at the forefront of the government's drive to make South Korea a hub for global clinical trials, has signed a strategic alliance agreement to take part in Quintiles' Prime Site program